WATERS CORP (WAT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for WAT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| WAT | Director | 70 | ["internationally recognized scientist","strong background in genomics, infectious diseases and molecular diagnostics","leader of two large research institutes for over 30 years","director of several biotechnology companies and non-profit organizations","experience working with a multinational company","enterprise risk management","director of Becton, Dickinson and Company"] | ["Science and Technology"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BDX | Former Director, Institute for Genome Sciences. University of Maryland School of Medicine | 70 | [] | [] | 2025 |
Biography sourced from the proxy statement filing.
Age: 70 COMMITTEES Science and Technology Dr. Fraser is an internationally recognized scientist who contributes deep scientific expertise and significant managerial experience to the Board, stemming from her strong background in genomics, infectious diseases and molecular diagnostics as well as her experience as the leader of two large research institutes for over 30 years and as a director of several biotechnology companies and non-profit organizations. Widely recognized as a scientific leader in microbiology and genomic medicine and has received a number of awards, including the E.O. Lawrence Award from the Department of Energy, the Promega Biotechnology Award from the American Society of Microbiology and the Charles Thom Award from the Society for Industrial Microbiology. Brings experience working with a multinational company in global markets as well as enterprise risk management as a result of her long tenure as a director of Becton, Dickinson and Company. CAREER HIGHLIGHTS University of Maryland School of Medicine Director, Institute for Genome Sciences (2007 2024), Professor Emerita of Medicine and Microbiology and Immunology (2007 2024) The Institute for Genomic Research President and Director (1998 2007) American Association for the Advancement of Science Chair of the Board and Director (2021) OTHER PUBLIC COMPANY BOARDS Seres Therapeutics, Inc. (NASDAQ: MCRB) (2023 present) FORMER (PAST 5 YEARS) Becton, Dickinson and Company Director (2006 2026) EDUCATION BS, Rensselaer Polytechnic Institute Ph.D., State University of New York at Buffalo